Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2168|102|10|1250-1257

ISSN： 0007-1323

Source： BRITISH JOURNAL OF SURGERY, Vol.102, Iss.10, 2015-09, pp. : 1250-1257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 2, 2015-02 ,pp. : 187-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 24, Iss. 1, 2018-01 ,pp. : 44-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 895-904

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating ischaemia‐reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 9, 2015-11 ,pp. : 1101-1110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating ischaemia‐reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 9, 2015-11 ,pp. : 1101-1110

John Wiley & Sons Inc

Access to resources Recommend Favorite